Every once in a while, we meet a client whose story reminds us exactly why we do what we do
Antibody formation occurs in some patients, particularly with exenatide, though this rarely has clinical significance
and the Pharmacy Compounding Advisory Committee subsequently voted against adding it to the Category 1/503A bulk drug substances list at its late-2024 meetings, leaving it without a confirmed legal compounding pathway at that time
Conversely, fatigue is a recognized side effect, particularly during initial treatment
There is a wide range of cardioprotective benefits to GLP-1R agonists in addition to their metabolic effects on blood glucose, adiposity, serum lipids, and blood pressure [31]
Pfizer agreed to acquire Metsera for $4.9 billion or $47.50 per share in cash at closing